April 08, 2021

Liva Healthcare collaborates with consortium of EU bodies to provide innovative cardiac rehabilitation

Liva Healthcare, a European market leader in scalable digital health coaching, has announced its participation in a new partnership collaboration initiative to make cardiac rehabilitation accessible to more patients in the immediate aftermath of a heart attack. Liva Healthcare is part of a consortium of EU bodies led by Amgen, a worldwide pioneer in biotechnology, to co-create an innovative digital tele-rehabilitation solution called Rehab+.

The European Institute of Innovation and Technology (EIT) Health recently announced that Rehab+ has won a prestigious Education Award, which enables Rehab+ to be implemented in four rehabilitation centres across Spain and the Netherlands and evaluated by Maastricht University (Center for Cardiology Research). Based on the scientific evaluation, further uptake of Rehab+ in Netherlands, Spain and additional countries will be discussed.

Rehab+ supports patients for over one year, helping them to transition from a passive, recovery mindset into an active one of self-care. Rehab+ is designed to help individuals assess their lifestyle post-heart attack, set personal objectives to reduce their cardiac risk, and establish long-lasting positive lifestyle changes. Rehab+ supports and equips patients to stay engaged with their own health and to manage their cardiac risk factors as a chronic condition to prevent a next heart attack.

A consortium to future-proof cardiac rehabilitation

To develop Rehab+, Amgen collaborated with Liva Healthcare, rehabilitation hospitals in Spain, La Paz in Madrid, Vall d’Hebron in Barcelona, Virgen de la Victoria in Malaga and Zuyderland in the Netherlands. Amgen also partnered with regional payors in Spain, Servicio Madrileño de Salud (SERMAS), Servicio Andaluz de Salud (SAS) and Servicio Català de la Salut (Cat Salut), and Maastricht University in the Netherlands. Rehab+ is endorsed by Spanish Society of Cardiology (SEC), Netherlands Society of Cardiology (NVVC) and Foro Español de Pacientes (Spanish Patients Forum).

Liva Healthcare will provide the technology platform, including the patient app. Through the app, patients will have regular support from a professional human coach and receive educational content based on their personal needs and situation. Patients can also track their own progress real-time and engage with a support group of peers to keep them motivated.

Rehab+ is part of OPTIMISE, an Amgen-led cardiovascular programme which aims to transform patient care and demonstrate improvement in outcomes. This is achieved through a wide range of innovative initiatives which support the healthcare community and patients at high risk of cardiovascular disease.

Roman Stampfli, Vice President Marketing & Innovation at Amgen, says:

“Only a third of the one million people who have a heart attack each year in Europe have access to cardiac rehabilitation to reduce their risk of a second heart attack,” says Roman Stampfli, Vice President Marketing & Innovation at Amgen. “This consortium is part of our commitment to make cardiac rehabilitation accessible to more patients in the immediate aftermath of a heart attack. By collaborating with Liva Healthcare and the consortium of EU partners, we can co-create an innovative digital tele-rehab solution that helps people establish long-lasting lifestyle changes.”

André Sode, CEO of Liva Healthcare, says:

“Amgen is addressing a significant gap in cardiac recovery. We are delighted to collaborate with Amgen, and a powerful collective of purpose-driven organisations, to help improve the lives of people who have had a heart attack,” says André Sode, CEO of Liva Healthcare. “By combining our technology and the expertise of Amgen and the consortium of partners, we can make cardiac rehabilitation easily accessible to more people, empowering them to stay engaged with their own health and, ultimately, reduce their risk of a next heart attack.”


Contact  

Jonas Damsgaard, Head of PR & Communications, jdj@livahealth.com

Related articles

October 17, 2022

Breakthrough RCT study shows efficacy of the Liva programme in producing sustained weight loss
A new study led by the Department of Public Health at the University of Southern Denmark and Liva Healthcare found that digital health coaching is more effective than traditional or non-digital care in ensuring sustained weight loss in people with type 2 diabetes and obesity over a 12-month period.   The randomised controlled study, published […]
Read more

October 12, 2022

Liva appoints new CEO to supercharge global growth
COPENHAGEN, Denmark, October 12, 2022 Liva Health, one of Europe’s leading evidence-based digital health coaching providers, is pleased to announce the appointment of Shahram Sharif as its new group CEO. Sharif will focus on Liva Health’s ambition of scaling up its digital services of tackling chronic conditions through digital tools that deliver significant clinical outcomes, […]
Read more

September 20, 2022

Liva Health agrees exclusive rights to SMASH’s innovative offer platform and app
At Liva Health we’re dedicated to evolving the way we approach chronic diseases through safe, sustainable lifestyle changes delivered by digital health coaching. SMASH (Save Money And Stay Healthy) is tackling obesity by helping young people develop a better relationship with food through education and access to better-for-you food and drink options. We both understand […]
Read more
NHS logo

May 29, 2022

Liva and LWTC to provide greater coverage and choice to participants as part of the successful NHS Diabetes Prevention Programme
Almost one million people have been referred to the NHS DPP since it launched in 2016, with participants who complete achieving an average weight loss of 3.3kg 29th May 2022 – In connection with the Type 2 Diabetes Prevention Week in the UK – a joint initiative between Diabetes UK and NHS England to raise […]
Read more